Tissue genomic testing
Molecular analysis performed on tumour tissue, usually from an existing biopsy or resection specimen.
Molecular testing
Look beyond the diagnosis.
Molecular testing is a clinical decision, not a default. The right test is the one that answers a question capable of changing what happens next.
What can be tested
Types of testing.
Comprehensive genomic profiling
Broader panels covering many genes at once, considered when a wider view of tumour biology is clinically relevant.
Liquid biopsy
Blood-based testing, useful when tissue is limited or when repeat sampling would be difficult.
ctDNA analysis
Circulating tumour DNA, used in selected situations for characterisation or monitoring.
Germline testing
Assessment of inherited predisposition, with genetic counselling considerations discussed beforehand.
Biomarker testing
Specific markers with diagnostic, prognostic or predictive relevance for a given cancer type.
Immunohistochemistry
Protein expression studies read alongside morphology by molecular pathology.
Molecular pathology review
Existing slides and reports reviewed so that testing already performed is not needlessly repeated.
The pathway
From sample to clinical discussion.
- 01Sample
- 02Laboratory
- 03Molecular analysis
- 04Interpretation
- 05Clinical discussion
Testing may be performed through accredited partner laboratories. The interpretation and clinical discussion take place at the institute.
Being clear
What a molecular report can and cannot tell you.
- A report may find no alteration of clinical relevance.
- An alteration may have no established treatment implication.
- Results are interpreted alongside pathology, imaging and clinical history — never in isolation.
Unsure whether molecular testing is worth doing?
That question is itself a good reason for a consultation.